Diagnostic errors in pathology do not make headlines the way medication errors or surgical complications do, but their consequences for patients can be equally serious. A biopsy specimen misidentified at the time of accessioning. A case report released with the wrong patient demographics. A finding missed on a slide reviewed late in the day when attention is stretched. A critical value that did not trigger the right notification pathway. These are the kinds of errors that pathology quality improvement programs spend enormous energy trying to prevent, and that automation and AI are increasingly positioned to address.
Where Pathology Errors Actually Come From
To understand why automation helps with error reduction, it is useful to understand where pathology errors actually originate. Research on diagnostic errors in pathology has identified several consistent categories:
- Pre-analytical errors: things that happen before the pathologist ever sees the specimen, including mislabeling, requisition information that does not match the specimen, or processing steps that were incorrectly executed. Some studies suggest these account for the majority of total laboratory errors.
- Analytical errors: problems with the actual diagnostic interpretation. These get more attention because they are perceived as the core function of the pathologist, but they are statistically less common than pre-analytical failures.
- Post-analytical errors: problems with how results are reported, communicated, or acted upon, including transcription errors, missed critical value notifications, and incomplete reporting.
How Basic Automation Reduces Pre-Analytical Errors
Automation addresses different categories of error in different ways. Barcoding and automated specimen tracking, which many labs have implemented, directly reduce the rate of specimen mislabeling errors by creating a system where the identity of a specimen is verified electronically at each step of the workflow rather than relying on manual verification. Labs that have implemented comprehensive barcode tracking report significant reductions in specimen identity errors compared to baseline rates.
Moving up the sophistication ladder, modern LIS platforms with built-in quality checkpoints can catch a wider range of process errors by enforcing structured workflows. If a specimen cannot proceed to the next stage until required information is documented, then the gaps that used to slip through get caught at the point of occurrence rather than discovered downstream when they are harder to address. This is a fundamentally different model than the old approach, where quality control meant reviewing completed work for errors after they had already propagated through the system.
NovoPath’s Preventive Approach to Quality
NovoPath’s pathology lab software incorporates workflow enforcement capabilities that reflect this preventive approach to quality management. Rather than relying on staff to remember every required step in a complex workflow, the system guides users through structured processes and requires completion of required steps before allowing progression. For labs that have struggled with variability in how different staff members execute the same processes, particularly relevant in labs with high turnover or mixed experience levels, this kind of system-enforced consistency can substantially reduce the variation that leads to errors.
AI as a Second Reader
AI introduces additional error-reduction capabilities, particularly in the analytical phase. AI-assisted image analysis can function as a second-reader for specific diagnostic tasks, reviewing slides systematically and flagging areas of concern that warrant closer pathologist attention. This is not about replacing pathologist judgment. Every lab that has implemented AI analysis tools emphasizes that the pathologist remains responsible for the diagnosis. It is about adding a layer of systematic review that is consistently thorough in a way that human review under high-volume conditions cannot always be.
Post-Analytical Error Reduction
The post-analytical phase is another area where automation is reducing errors meaningfully. Specific improvements include:
- Automated critical value notification systems ensure urgent results trigger the appropriate communication pathways without depending on a staff member remembering to make a phone call
- Structured reporting templates reduce variability in how results are expressed, making it easier for ordering clinicians to find key information and reducing the risk of misinterpretation
- EHR integration that delivers results directly without manual transcription eliminates a category of transcription errors entirely
- Electronic attestation workflows ensure every report has been reviewed and signed before release
What the Data Reveals About Lab Performance
One of the less obvious error-reduction benefits of modern LIS systems is the data they generate about process performance. When a lab has an information system that tracks every case through every stage of the workflow, it accumulates data that can be analyzed to identify patterns. Cases that consistently get stuck at a particular stage might indicate a bottleneck or a process design problem. A spike in amendment rates for a particular pathologist or a particular test type might indicate a training need. This kind of performance monitoring is essentially impossible in a manual system.
Reducing errors in pathology lab workflows is ultimately a patient safety issue. The reports coming out of a pathology lab drive treatment decisions including whether a surgeon resects more tissue, whether a patient starts chemotherapy, and whether a worrying finding gets followed up or is determined to be benign. Automation and AI do not change that purpose. They provide better tools for achieving it.
